Calycosin, at a concentration of 50 μmol/L, has been demonstrated to decrease the expression of extracellular signal-regulated kinases, upstream nuclear factor-κB (NF-κB), and signal transducer and activator of transcription 3 (STAT3), in gastric cancer cells. Here, STAT3 is linked to gastric cancer.